BCL2L1 and colorectal carcinoma: In TRAF4-knockout xenograft tumors, the introduction of Bcl-xL markedly attenuated the inhibitory effect of irradiation and rescued tumorigenesis in TRAF4-null CRC cells, even with irradiation treatment (Fig. 6D).